Key facts
- This page summarizes Jonathan H. Kaufman's Form 4 filing for LIPELLA PHARMACEUTICALS INC. (LIPO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 15 May 2024, 16:39.
Jonathan H. Kaufman - 14 May 2024 Form 4 Insider Report for LIPELLA PHARMACEUTICALS INC. (LIPO)
- Reporting relationship
- President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors, Director, 10%+ Owner
- Issuer ticker
- LIPO
- Reported as of
- 14 May 2024
- Net transaction value
- +$7,590
- SEC form
- 4
- Accepted by SEC
- 15 May 2024, 16:39:19 UTC
- Prior SEC filing
- 19 Mar 2024
- Next SEC filing
- 27 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jonathan H. Kaufman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Jonathan H. Kaufman filed Form 4 for LIPELLA PHARMACEUTICALS INC. (LIPO) on 15 May 2024.
Change
- Previous filing in this sequence was filed on 19 Mar 2024.
- Current net transaction value: +$7,590.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LIPO
transaction
Common Stock
Purchase
- Transaction value
- $7,590
- Shares
- +10,000
- Change %
- +1.1%
- Price
- $0.7590
- Shares after
- 898,849
- Date
- 14 May 2024
- Ownership
- Direct
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Open market purchase by the reporting person of 10,000 shares of common stock, par value $0.0001 per share (the "Common Stock").
Footnote F2
Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on May 14, 2024 at prices ranging from $0.7552 to $0.76 per share, inclusive. The amount reflected has been rounded to 3 decimal points.
Footnote F3
The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range.
SEC remarks
President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors